Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

Read about exa-cel being rolled out on the NHS, providing a 'functional cure' for some patients with severe sickle cell ...

Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University. Crispr designed gene cutting ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...